Phase I Clinical Trial for AI-Designed Drug Formulation

Quotient Sciences has successfully initiated a clinical study evaluating a novel drug product developed using AI

Sino Biological’s cell-free protein synthesis used in study

The protein design study aimed to validate AI-designed proteins with improved activity, stability and multifunctionality

New range of cell lines from Amsbio

The addition offers over 1,000 cell lines covering a range of tumours and tissues

Partnership to accelerate drug development

AI/ML predictive models will be integrated into an electronic notebook to support workflows

News

Subscribe to our Newsletter

© 2026 Setform Limited.